The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial. (2018)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3233/JAD-170101

PubMed Identifier: 29226862

Publication URI: http://europepmc.org/abstract/MED/29226862

Type: Journal Article/Review

Volume: 61

Parent Publication: Journal of Alzheimer's disease : JAD

Issue: 2

ISSN: 1387-2877